HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shiuan Chen Selected Research

Aromatase (CYP19)

1/202111-Oxygenated Estrogens Are a Novel Class of Human Estrogens but Do not Contribute to the Circulating Estrogen Pool.
1/2016Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.
6/2015AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens.
6/2014Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice.
5/2014AroER tri-screen is a biologically relevant assay for endocrine disrupting chemicals modulating the activity of aromatase and/or the estrogen receptor.
6/2013The citrus flavonone hesperetin prevents letrozole-induced bone loss in a mouse model of breast cancer.
5/2013Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy.
10/2012The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice.
5/2011Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?
2/2011Growth factor signaling enhances aromatase activity of breast cancer cells via post-transcriptional mechanisms.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shiuan Chen Research Topics

Disease

93Breast Neoplasms (Breast Cancer)
01/2022 - 04/2002
66Neoplasms (Cancer)
01/2022 - 04/2002
7Prostatic Neoplasms (Prostate Cancer)
08/2021 - 05/2007
7Triple Negative Breast Neoplasms
05/2021 - 05/2010
4Carcinogenesis
06/2013 - 06/2003
3Obesity
01/2018 - 10/2010
3Neoplasm Metastasis (Metastasis)
01/2014 - 05/2011
3Body Weight (Weight, Body)
11/2013 - 03/2009
2Inflammation (Inflammations)
01/2014 - 10/2011
2Hypoxia (Hypoxemia)
02/2011 - 04/2009
2Carcinoma (Carcinomatosis)
11/2009 - 06/2003
2Hepatocellular Carcinoma (Hepatoma)
08/2003 - 01/2003
1Mitochondrial Diseases (Mitochondrial Disease)
12/2021
1Human Influenza (Influenza)
08/2021
1COVID-19
03/2021
1Cytokine Release Syndrome
03/2021
1Adrenocortical Carcinoma
01/2021
1Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
01/2021

Drug/Important Bio-Agent (IBA)

52Estrogens (Estrogen)FDA Link
01/2022 - 06/2002
49Aromatase (CYP19)IBA
01/2021 - 04/2002
40Aromatase InhibitorsIBA
12/2021 - 06/2002
33Estrogen ReceptorsIBA
01/2022 - 06/2003
33Hormones (Hormone)IBA
12/2021 - 11/2002
19AndrogensIBA
08/2021 - 11/2002
17EnzymesIBA
01/2022 - 01/2003
14Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2002
12Letrozole (Femara)FDA LinkGeneric
11/2021 - 11/2004
9Biological ProductsIBA
08/2021 - 01/2009
7Phosphotransferases (Kinase)IBA
04/2019 - 04/2005
7Messenger RNA (mRNA)IBA
10/2012 - 06/2003
7TamoxifenFDA LinkGeneric
09/2012 - 04/2005
6exemestane (Aromasin)FDA Link
11/2021 - 11/2004
6Anastrozole (Arimidex)FDA LinkGeneric
11/2021 - 11/2004
6Androgen Receptors (Androgen Receptor)IBA
08/2021 - 06/2003
6PhytochemicalsIBA
05/2010 - 09/2003
5RNA (Ribonucleic Acid)IBA
12/2021 - 01/2019
5Pharmaceutical PreparationsIBA
04/2019 - 04/2005
5Estrogen Receptor alphaIBA
01/2017 - 06/2003
5Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2014 - 06/2009
5Androstenedione (4 Androstene 3,17 dione)IBA
10/2008 - 08/2003
4Dihydrotestosterone (Androstanolone)IBA
08/2021 - 11/2013
4CytokinesIBA
03/2021 - 06/2012
4Fulvestrant (Faslodex)FDA Link
01/2018 - 09/2010
4ElementsIBA
06/2015 - 04/2002
4nimesulide (Aulin)IBA
08/2011 - 06/2009
4Testosterone (Sustanon)FDA Link
01/2010 - 08/2003
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 11/2013
3AmphiregulinIBA
12/2021 - 04/2008
3Halogenated Diphenyl EthersIBA
11/2021 - 01/2019
3sapanisertibIBA
04/2019 - 01/2018
3Cyclin D1IBA
06/2018 - 10/2012
3Estrogen Receptor Modulators (Antiestrogen)IBA
01/2018 - 04/2005
3GlucocorticoidsIBA
01/2017 - 02/2014
3PowdersIBA
09/2015 - 10/2011
3PanobinostatIBA
06/2015 - 06/2010
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2011 - 06/2009
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2011 - 12/2008
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2011 - 05/2005
3Gonadal Steroid Hormones (Sex Hormones)IBA
02/2010 - 06/2003
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
03/2009 - 01/2008
2pentabromodiphenyl ether (PBDE)IBA
11/2021 - 01/2019
2Biomarkers (Surrogate Marker)IBA
11/2021 - 09/2015
2Peptide Hydrolases (Proteases)FDA Link
08/2021 - 03/2021
2Serine Proteases (Serine Protease)IBA
08/2021 - 03/2021
2Peptides (Polypeptides)IBA
05/2021 - 12/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2021 - 12/2019
2ErbB Receptors (EGF Receptor)IBA
12/2020 - 09/2015
2AcidsIBA
12/2019 - 01/2010
2Cyclin-Dependent Kinases (cdk Proteins)IBA
04/2019 - 05/2007
2palbociclibIBA
04/2019 - 06/2018
2TOR Serine-Threonine KinasesIBA
04/2019 - 01/2018
2Phenobarbital (Luminal)FDA Link
01/2019 - 01/2017
2EverolimusFDA Link
08/2018 - 07/2005
2Trastuzumab (Herceptin)FDA Link
01/2018 - 11/2008
2Progesterone Receptors (Progesterone Receptor)IBA
09/2015 - 06/2003
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
07/2015 - 01/2011
2Mitogen-Activated Protein KinasesIBA
07/2015 - 12/2008
2Histone Deacetylase InhibitorsIBA
06/2015 - 01/2013
2LuciferasesIBA
06/2015 - 05/2014
2Transcription Factors (Transcription Factor)IBA
05/2015 - 05/2005
2MicroRNAs (MicroRNA)IBA
06/2014 - 11/2010
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
06/2014 - 05/2010
2hesperetinIBA
06/2013 - 10/2012
2Conjugated Linoleic AcidsIBA
10/2010 - 01/2008
2Estradiol (Delestrogen)FDA LinkGeneric
02/2010 - 04/2005
2SteroidsIBA
09/2008 - 06/2003
2Estrogen Receptor betaIBA
05/2007 - 06/2003
2PolyphenolsIBA
07/2006 - 05/2005
2ERRalpha Estrogen-Related ReceptorIBA
05/2005 - 03/2005
1ThioredoxinsIBA
01/2022
1Inositol (Myoinositol)IBA
01/2022
1CalciumIBA
12/2021
1hydrogen sulfite (bisulfite)IBA
11/2021
1Phytoestrogens (Phytoestrogen)IBA
08/2021
1Keratin-1IBA
05/2021
1Cell Surface ReceptorsIBA
05/2021
1enzalutamideIBA
01/2021
1LigandsIBA
12/2020

Therapy/Procedure

26Therapeutics
12/2021 - 06/2002
1Drug Therapy (Chemotherapy)
05/2021